BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4069347)

  • 1. The metyrapone test in schizophrenic patients and healthy subjects.
    Morphy MA; Fava GA; Carson SW; Perini GI; Molnar G; Jusko WJ
    Neuropsychobiology; 1985; 14(1):35-8. PubMed ID: 4069347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metyrapone test in affective disorders and schizophrenia.
    Fava GA; Carson SW; Perini GI; Morphy MA; Molnar G; Jusko WJ
    J Affect Disord; 1984 Jun; 6(3-4):241-7. PubMed ID: 6235255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metyrapone test in manic patients and healthy subjects.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    Pharmacopsychiatry; 1984 May; 17(3):94-7. PubMed ID: 6739539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metyrapone test in depressed males.
    Morphy MA; Fava GA; Perini GI; Molnar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):187-91. PubMed ID: 4001433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
    Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.
    Calis M; Gökçe C; Ates F; Ulker S; Izgi HB; Demir H; Kirnap M; Sofuoglu S; Durak AC; Tutus A; Kelestimur F
    J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
    Thorén M; Stenfors C; Apéria B; Mathé AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):319-26. PubMed ID: 2359842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapid beta 1-24-corticotropin test in the exploration of the corticotropic axis. 71 cases].
    Chaieb L; Vidal-Trecan G; Laudat MH; Guilhaume B; Bertagna X; Bricaire H; Luton JP
    Presse Med; 1984 Oct; 13(36):2183-7. PubMed ID: 6095244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 30 Min ACTH stimulation test as predictor of hypothalamic-pituitary-adrenocortical function. Comparison with metyrapone test.
    Blichert-Toft M; Lindholm J; Kehlet H
    Acta Med Scand; 1980; 207(1-2):115-7. PubMed ID: 6245561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagal effects of endocrine HPA axis challenges on resting autonomic activity assessed by heart rate variability measures in healthy humans.
    Agorastos A; Heinig A; Stiedl O; Hager T; Sommer A; Müller JC; Schruers KR; Wiedemann K; Demiralay C
    Psychoneuroendocrinology; 2019 Apr; 102():196-203. PubMed ID: 30579237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
    Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder.
    Yehuda R; Levengood RA; Schmeidler J; Wilson S; Guo LS; Gerber D
    Psychoneuroendocrinology; 1996 Jan; 21(1):1-16. PubMed ID: 8778898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N; Mück-Seler D; Jakovljević M
    Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls.
    Morphy MA; Fava GA; Pedersen RC; Zielezny M; Sonino N; Brownie AC
    J Affect Disord; 1990 Jul; 19(3):183-9. PubMed ID: 2170484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal function in extrinsic asthma.
    Morrish DW; Sproule BJ; Aaron TH; Outhet D; Crockford PM
    Chest; 1979 Feb; 75(2):161-6. PubMed ID: 217570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the three hour metyrapone test in adults.
    Best JD; Alford FP; Donald RA
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):69-76. PubMed ID: 6254698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
    Mück-Seler D; Pivac N; Jakovljević M; Brzović Z
    Biol Psychiatry; 1999 Jun; 45(11):1433-9. PubMed ID: 10356625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
    Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.